Background illustration for clinical trials search

Paid Clinical Trials Irving

Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation

for
Alzheimers Disease, Dementia, Alzheimers Disease, Familial
Location: Dallas TX, St Louis MO, Birmingham AL, Atlanta GA,
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT05552157

Phase 2, Phase 3, Recruiting
Active & Responsive

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

for
Primary Myelofibrosis (PMF),
Location: Dallas TX, Tyler TX, Austin TX, Houston TX, Denver CO,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07357727

Phase 3, Recruiting
Active & Responsive

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

for
Triple Negative Breast Neoplasms
Location: Dallas TX, Houston TX, San Antonio TX, Hattiesburg MS,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06841354

Phase 3, Recruiting
Active & Responsive

A Study to Evaluate Efficacy, Safety, and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)

for
Chronic Pruritus of Unknown Origin
Location: Grapevine TX, Sugarland TX, San Antonio TX,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07811869

Phase 3, Recruiting
Active & Responsive

IEEM-Heat and Heart Failure

for
Heart Failure, Hyperthermia
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 45+

Code: NCT06961929

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Leg Heating in Pregnant Women With Obesity

for
High-risk Pregnancy
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: Female

Age: 18 - 45

Code: NCT06932250

Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

for
NASH - Nonalcoholic Steatohepatitis,
Location: Arlington TX, Dallas TX, Denison TX, Waco TX,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06528314

Phase 3, Recruiting
Active & Responsive

Healthy Living BEYOND Weight Study

for
Overweight or Obesity
Location: Dallas TX
Sponsor: American Heart Association

Sex: All

Age: 18+

Code: NCT07075341

Recruiting
Active & Responsive

Pivotal Study of the Velocity™ pAVF System

for
Chronic Kidney Disease, Hemodialysis Access,
Location: Dallas TX, Humble TX, San Antonio TX, Houston TX,
Sponsor: Venova Medical

Sex: All

Age: 18 - 70+

Code: NCT07153939

Recruiting
Active & Responsive

A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors

for
Solid Tumor
Location: Dallas TX, Oklahoma City OK, Nashville TN, Augusta GA,
Sponsor: Biohaven Therapeutics Ltd.

Sex: All

Age: 18+

Code: NCT06384807

Phase 1, Phase 2, Recruiting
Active & Responsive

A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases

for
Solid Tumor Malignancies, Brain Metastases From Solid Tumors
Location: Dallas TX, Oklahoma City OK, Houston TX, Charleston SC,
Sponsor: A2A Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT06136884

Phase 1, Recruiting
Active & Responsive

Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Dallas TX, Louisville KY, Huntersville NC,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06750185

Phase 1, Phase 2, Recruiting
Active & Responsive

A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors

for
Solid Tumor
Location: Dallas PA, Houston TX, Denver CO, Nashville TN,
Sponsor: Genentech, Inc.

Sex: All

Age: 18+

Code: NCT06619587

Phase 1, Recruiting
Active & Responsive

A Study of TAK-505 in Adults With Solid Tumors

for
Malignant Solid Tumors
Location: Dallas TX, Houston TX, San Antonio TX, Nashville TN,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT07436728

Phase 1, Phase 2, Recruiting
Active & Responsive

A Study of DM005 in Patients With Advanced Solid Tumors

for
Carcinoma, Non-Small-Cell Lung,
Location: Dallas TX, Detroit MI, Fairfax VA
Sponsor: Doma Biopharmaceutical(Suzhou)Co., Ltd.

Sex: All

Age: 18+

Code: NCT06515990

Phase 1, Phase 2, Recruiting
Active & Responsive

A Study to Investigate the Safety and Efficacy of KQB168 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

for
Solid Tumor Malignancies
Location: Dallas TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: Kumquat Biosciences Inc.

Sex: All

Age: 18+

Code: NCT06994806

Phase 1, Recruiting
Active & Responsive

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

for
NASH With Fibrosis, MASH With Fibrosis
Location: Dallas TX, Fort Worth TX, Forney TX, Denison TX,
Sponsor: Akero Therapeutics, Inc

Sex: All

Age: 18 - 70+

Code: NCT06215716

Phase 3, Recruiting
Active & Responsive

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

for
Obesity, Overweight
Location: Dallas TX, Austin TX, Houston TX, San Antonio TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT06143956

Phase 2, Recruiting
Active & Responsive

A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

for
Migraine
Location: Dallas TX, DeSoto TX, Austin TX, Tomball TX,
Sponsor: TriGemX Bio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07816367

Phase 3, Recruiting
Active & Responsive

A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy

for
Kidney Disease
Location: Dallas TX, Shreveport LA, Katy TX, Houston TX,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06963827

Phase 3, Recruiting